Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT [Phase 2]
This Phase 2 trial comparing post-transplant cyclophosphamide (PTCy) plus ruxolitinib versus PTCy with tacrolimus and MMF in matched related…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep [Phase 2]
Phase 2 clinical trial evaluating non-myeloablative preparative regimens followed by umbilical cord blood transplantation for various hemato…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of uproleselan in combination with chemotherapy for Chinese patients with relapsed/…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML [Phase 3]
Phase 3 trial evaluating Uproleselan in combination with chemotherapy for Relapsed/Refractory acute myeloid leukemia in Chinese patients has…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation [Phase 1, Phase 2]
Open-label Phase 1/2 trial of FT-2102 in IDH1-mutant acute myeloid leukemia and myelodysplastic syndrome, evaluating FT-2102 with or without…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: CART-38 in Adult AML and MM Patients [Phase 1]
Phase 1 study of CART-38 in adults with acute myeloid leukemia and multiple myeloma has been terminated; this update notes the status of the…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia [NA]
A completed feasibility study evaluating telehealth palliative care and digital symptom monitoring for patients with Acute Myeloid Leukemia.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study of E7820 in People With Bone Marrow (Myeloid) Cancers [Phase 2]
Phase 2 study of E7820 in people with bone marrow (myeloid) cancers, including Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Chroni…
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia [Phase 1]
A Phase 1 clinical trial evaluating total marrow and lymphoid irradiation with chemotherapy before donor transplantation in patients with my…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Evaluation of 3 Different Doses of IV Busulfan [Phase 2]
Clinical Trial Update on a Phase 2 study evaluating three different doses of intravenous busulfan in patients with myelodysplastic syndrome …
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases [Phase 2]
A Phase 2 clinical trial is testing alpha/beta T cell and CD19+ B cell depletion in allogeneic stem cell transplantation for malignant disea…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome [Phase 3]
Phase 3 trial evaluating response-based chemotherapy in younger patients with Down syndrome who have newly diagnosed acute myeloid leukemia …
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes [Phase 1]
A Phase 1 dose-finding study of CC-90009 in adults with relapsed or refractory acute myeloid leukemia or relapsed/refractory higher-risk mye…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial evaluates WBC100 Capsule in relapsed/refractory acute myeloid leukemia. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD [Phase 2]
Phase 2 clinical trial assessing selective depletion of CD45RA+ T cells from allogeneic stem cell grafts to prevent graft-versus-host diseas…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation [Phase 2]
Phase 2 trial comparing three GVHD prophylaxis regimens in nonmyeloablative or reduced-intensity conditioning unrelated donor transplantatio…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating HAD induction with intensified cytarabine in newly diagnosed CEBPA double-mutated acute myeloid leukemia; …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation. [Phase 1, Phase 2]
A clinical trial update reports that Sabatolimab was studied for acute myeloid leukemia with measurable residual disease after allogeneic st…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial is evaluating the safety and preliminary efficacy of a CD38 and CLL-1 dual-target CAR-T cell therapy for relapsed o…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Combined With Chemotherapy in Untreated de Novo Acute Myeloid Leukemia [NA]
Clinical trial update on the use of mitoxantrone hydrochloride liposome in combination with chemotherapy for untreated de novo acute myeloid…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia [Phase 1, Phase 2]
Results from a Phase I/II trial evaluating CPX-351 in combination with palbociclib for acute myeloid leukemia have been completed with poste…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
A completed clinical trial assessed the safety of Xospata (gilteritinib) in patients with relapsed or refractory acute myeloid leukemia harb…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial of CC-96191 in participants with relapsed or refractory acute myeloid leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML [Phase 2]
A Phase 2 trial evaluated the efficacy of the idarubicin, cytarabine, and cyclophosphamide (IAC) regimen in relapsed/refractory acute myeloi…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Efficacy and Safety of Chidamide in CBF Leukemia [Phase 1, Phase 2]
Phase 1/2 trial update reports on the efficacy and safety of chidamide in patients with acute myeloid leukemia; the study is currently activ…